Sanand Ratnam Thekkayil

MD(Ayurveda)
Chief Medical Officer
India

Abstract Title: Regional Wall Motion Improvement Documented by Serial Echocardiography after Ayurvedic Care

Biography:

Dr. Sanand Ratnam, BAMS, MD (Ayurveda), is a fourth-generation Ayurvedic physician from the Thekkayil family and Chief Medical Officer at Sri Subramania Ayurvedic Nursing Home, Kerala, India. He practices classical clinical Ayurveda supported by modern diagnostic evaluation, focusing on functional restoration in chronic diseases through individualized treatment protocols. He provides in-person and international teleconsultations, has attended multiple medical conferences in Europe, and maintains professional healthcare collaborations there. He is a member of the British Society for Rheumatology and is academically interested in documenting objective outcomes of traditional therapies using contemporary clinical parameters.

Research Interest:

Functional myocardial abnormalities detected on echocardiography are commonly managed with the expectation of long-term control rather than reversal, particularly in elderly patients. The present clinical observation documents objective improvement demonstrated through serial cardiac imaging following a structured Ayurvedic therapeutic program. A 65-year-old female presented with exertional dyspnea, easy fatigability, and progressive reduction in routine physical capacity. Baseline echocardiography performed on 02 September 2024 revealed distal septal and apical hypokinesia, Grade I left ventricular diastolic dysfunction, mild mitral regurgitation, and a left ventricular ejection fraction (LVEF) of 55%. Management was designed according to classical Ayurvedic clinical assessment, focusing on restoration of circulatory integrity and myocardial tissue nutrition. Treatment was implemented in staged phases, including metabolic correction, systemic channel regulation, and cardiac functional support using internal medications and supervised therapeutic procedures. The therapeutic objective emphasized normalization of cardiac physiology rather than symptomatic palliation. Follow-up echocardiography performed on 15 December 2025 demonstrated complete resolution of regional wall motion abnormality, normal left ventricular systolic function with LVEF 71%, absence of pulmonary hypertension, and only trivial mitral regurgitation with normal cardiac chamber dimensions. This observation documents measurable functional recovery based on objective imaging parameters. The findings suggest that selected forms of myocardial dysfunction associated with circulatory and metabolic disturbance may possess reversible potential. Systematic controlled clinical studies integrating modern diagnostic parameters are warranted to further evaluate the role of traditional therapeutic interventions in functional cardiac disorders.